Literature DB >> 26205181

Pigmented hepatocellular adenomas have a high risk of atypia and malignancy.

Taofic Mounajjed1, Saba Yasir1, Patrice A Aleff1, Michael S Torbenson1.   

Abstract

Pigment deposition is occasionally seen in hepatocellular adenomas. Several reports suggest that pigmented hepatocellular adenomas have increased risk of malignancy, but these tumors remain incompletely understood. To determine the frequency of pigment deposition, we evaluated and classified 109 well-differentiated hepatocellular neoplasms that were originally diagnosed or submitted in consultation as hepatocellular adenomas and found 27 (25%) pigmented tumors. All were negative on iron stain and in three cases electron microscopy confirmed the pigment was lipofuscin. The lipofuscin intensely stained with glypican-3 in most cases (89%). Of the 27 pigmented tumors, 11 cases (41%) were classified as hepatocellular adenomas, 7 cases (27%) were classified as atypical hepatocellular adenomas/hepatocellular neoplasms of uncertain malignant potential, and 9 cases (33%) were reclassified as well-differentiated hepatocellular carcinomas. Four (of 9) hepatocellular carcinomas arose in pigmented hepatocellular adenomas, giving a rate of malignant transformation in pigmented hepatocellular adenomas of 27%. Of the total 27 pigmented tumors, 78% were in women and 22% in men, but interestingly only men had tumors classified as hepatocellular carcinoma or hepatocellular neoplasm of uncertain malignant potential. Also of note, a total of 10 individuals (37%) had multiple hepatocellular neoplasms but in 9 of these cases the other adenomas were non-pigmented. Importantly, in cases with multiple hepatocellular neoplasms, only the pigmented hepatocellular neoplasms had atypia or malignancy. Genotype-phenotype classification of the pigmented tumors showed different subtypes: HNF1α inactivated (48%), β-catenin activated (26%), inflammatory (15%), concurrently β-catenin activated and inflammatory in 1 hepatocellular adenoma, concurrently HNF-1α inactivated and β-catenin activated in 1 hepatocellular adenoma, and unclassified in 1 hepatocellular carcinoma. In conclusion, hepatocellular adenomas with lipofuscin pigment are a heterogeneous group of adenomas, with HNF-1α inactivation being the commonest genotype. They have an increased risk of atypia and malignancy, especially in males.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26205181     DOI: 10.1038/modpathol.2015.83

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  22 in total

1.  Pigmented liver cell adenoma in two male patients.

Authors:  N Hasan; M Coutts; B Portmann
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

2.  Senescence-associated oxidative DNA damage promotes the generation of neoplastic cells.

Authors:  Karo Gosselin; Sébastien Martien; Albin Pourtier; Chantal Vercamer; Peter Ostoich; Luc Morat; Laure Sabatier; Laurence Duprez; Claire T'kint de Roodenbeke; Eric Gilson; Nicolas Malaquin; Nicolas Wernert; Predrag Slijepcevic; Marjan Ashtari; Fazia Chelli; Emeric Deruy; Bernard Vandenbunder; Yvan De Launoit; Corinne Abbadie
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

3.  A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas.

Authors:  Safi Dokmak; Valérie Paradis; Valérie Vilgrain; Alain Sauvanet; Olivier Farges; Dominique Valla; Pierre Bedossa; Jacques Belghiti
Journal:  Gastroenterology       Date:  2009-08-05       Impact factor: 22.682

4.  Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.

Authors:  Susanna M van Aalten; Joanne Verheij; Turkan Terkivatan; Roy S Dwarkasing; Robert A de Man; Jan N M Ijzermans
Journal:  J Hepatol       Date:  2010-11-24       Impact factor: 25.083

5.  Changing trends in malignant transformation of hepatocellular adenoma.

Authors:  Olivier Farges; Nelio Ferreira; Safi Dokmak; Jacques Belghiti; Pierre Bedossa; Valérie Paradis
Journal:  Gut       Date:  2011-01       Impact factor: 23.059

6.  Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid.

Authors:  D S Marsman; T L Goldsworthy; J A Popp
Journal:  Carcinogenesis       Date:  1992-06       Impact factor: 4.944

Review 7.  Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.

Authors:  Sandra Rebouissou; Paulette Bioulac-Sage; Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2007-10-30       Impact factor: 25.083

8.  Pigmented hepatocellular adenoma with complete CD34 immunostaining pattern: a diagnostic dilemma.

Authors:  Mukul Vij; Sushma Patra; Mohamed Rela
Journal:  Indian J Pathol Microbiol       Date:  2012 Oct-Dec       Impact factor: 0.740

9.  Clinicopathological analysis of hepatocellular adenoma according to new bordeaux classification: report of eight korean cases.

Authors:  Hyunchul Kim; Ja-June Jang; Dong-Sik Kim; Beom Woo Yeom; Nam Hee Won
Journal:  Korean J Pathol       Date:  2013-10-25

10.  β-Catenin activated hepatocellular adenoma: a report of three cases in Korea.

Authors:  Gi Jeong Kim; Jae Yeon Seok; Hyungjin Rhee; Jin-Young Choi; Jin-Sub Choi; Kyung Sik Kim; Swan Thung; Young Nyun Park
Journal:  Gut Liver       Date:  2014-07-01       Impact factor: 4.519

View more
  8 in total

Review 1.  Hepatocellular Adenoma and Focal Nodular Hyperplasia.

Authors:  Taofic Mounajjed
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01

2.  Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.

Authors:  Juan Putra; Linda D Ferrell; Annette S H Gouw; Valerie Paradis; Arvind Rishi; Christine Sempoux; Charles Balabaud; Swan N Thung; Paulette Bioulac-Sage
Journal:  Mod Pathol       Date:  2019-09-30       Impact factor: 7.842

3.  Hepatic Adenomas in Patients 60 and Older Are Enriched for HNF1A Inactivation and Malignant Transformation.

Authors:  Saba Yasir; Zongming E Chen; Dhanpat Jain; Sanjay Kakar; Tsung-Teh Wu; Matthew M Yeh; Michael S Torbenson
Journal:  Am J Surg Pathol       Date:  2022-04-06       Impact factor: 6.298

4.  Hepatocellular adenoma: Where are we now?

Authors:  Xi Wang; Xuchen Zhang
Journal:  World J Gastroenterol       Date:  2022-04-14       Impact factor: 5.374

Review 5.  Hepatocellular adenomas: recent updates.

Authors:  Haeryoung Kim; Young Nyun Park
Journal:  J Pathol Transl Med       Date:  2021-04-07

6.  Biopsies of hepatocellular carcinoma with no reticulin loss: an important diagnostic pitfall.

Authors:  Saba Yasir; Zongming Eric Chen; Samar Said; Tsung-Teh Wu; Michael Torbenson
Journal:  Hum Pathol       Date:  2020-10-08       Impact factor: 3.526

7.  Giant hepatocellular carcinoma with bone metastasis in a young adult, emerged from pigmented adenoma with beta-Catenin activation: A case report.

Authors:  Sebastian Lünse; Paula Döring; Claus-Dieter Heidecke; Lars Ivo Partecke
Journal:  Int J Surg Case Rep       Date:  2017-05-03

8.  Unclassified hepatocellular adenoma with histological brown pigment deposition and serum PIVKA-II level elevation: a case report.

Authors:  Kouki Hoshino; Norifumi Harimoto; Ryo Muranushi; Kei Hagiwara; Takahiro Yamanaka; Norihiro Ishii; Mariko Tsukagoshi; Takamichi Igarashi; Akira Watanabe; Norio Kubo; Kenichiro Araki; Ran Tomomasa; Sumihito Nobusawa; Shinichi Aishima; Osamu Nakashima; Ken Shirabe
Journal:  Surg Case Rep       Date:  2020-05-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.